CombiMatrix Launches Preimplantation Genetic Diagnostic Testing for Single Gene Disorders and Chromosomal Translocations
05 avr. 2016 06h00 HE
|
CombiMatrix Corporation
IRVINE, Calif., April 05, 2016 (GLOBE NEWSWIRE) -- CombiMatrix Corporation (NASDAQ:CBMX), a molecular diagnostics company specializing in DNA-based testing services for prenatal and postnatal...
CombiMatrix Comments on Medical Policy Revisions by Cigna Health and Three BCBS Health Plans to Reimburse for Recurrent Pregnancy Loss Testing
29 mars 2016 06h00 HE
|
CombiMatrix Corporation
IRVINE, Calif., March 29, 2016 (GLOBE NEWSWIRE) -- CombiMatrix Corporation (NASDAQ:CBMX), a molecular diagnostics company specializing in DNA-based testing services for prenatal and postnatal...
CombiMatrix Closes $8.0 Million Underwritten Public Offering
24 mars 2016 09h59 HE
|
CombiMatrix Corporation
IRVINE, Calif., March 24, 2016 (GLOBE NEWSWIRE) -- CombiMatrix Corporation (NASDAQ:CBMX), a molecular diagnostics company specializing in DNA-based testing services for prenatal and postnatal...
CombiMatrix Corporation Reports 2015 Fourth Quarter and Full Year Financial and Operating Results
17 févr. 2016 16h05 HE
|
CombiMatrix Corporation
Revenue Growth of 21% for the Quarter Driven by Record Miscarriage Analysis and Pre-Implantation Genetic Screening Test VolumesConference Call Begins Today at 4:30 p.m. Eastern Time IRVINE, Calif.,...
CombiMatrix Regains Compliance With NASDAQ Minimum Bid Price Listing Requirement
17 févr. 2016 06h00 HE
|
CombiMatrix Corporation
IRVINE, Calif., Feb. 17, 2016 (GLOBE NEWSWIRE) -- CombiMatrix Corporation (NASDAQ:CBMX), a molecular diagnostics company specializing in DNA-based testing services for prenatal, miscarriage...
CombiMatrix Comments on Revised Reimbursement Policies for Recurrent Pregnancy Loss
11 févr. 2016 06h00 HE
|
CombiMatrix Corporation
IRVINE, Calif., Feb. 11, 2016 (GLOBE NEWSWIRE) -- CombiMatrix Corporation (NASDAQ:CBMX), a molecular diagnostics company specializing in DNA-based testing services for prenatal and postnatal...
CombiMatrix Migrates Miscarriage Analysis Microarray Testing to Newer Scanning Panel
09 févr. 2016 06h00 HE
|
CombiMatrix Corporation
IRVINE, Calif., Feb. 09, 2016 (GLOBE NEWSWIRE) -- CombiMatrix Corporation (NASDAQ:CBMX), a molecular diagnostics company specializing in DNA-based testing services for prenatal and postnatal...
CombiMatrix Corporation to Release 2015 Fourth Quarter and Full Year Financial Results on February 17, 2016
08 févr. 2016 06h00 HE
|
CombiMatrix Corporation
IRVINE, Calif., Feb. 08, 2016 (GLOBE NEWSWIRE) -- CombiMatrix Corporation (NASDAQ:CBMX) announces that it will release financial results for the three months and full year ended December 31, 2015...
CombiMatrix Study Published in Genetics in Medicine
01 févr. 2016 06h00 HE
|
CombiMatrix Corporation
IRVINE, Calif., Feb. 01, 2016 (GLOBE NEWSWIRE) -- CombiMatrix Corporation (NASDAQ:CBMX), a molecular diagnostics company specializing in DNA-based testing services for prenatal and postnatal...
CombiMatrix Announces Commercial Launch of Microarray Testing for Stillbirth Analysis
28 janv. 2016 06h00 HE
|
CombiMatrix Corporation
IRVINE, Calif., Jan. 28, 2016 (GLOBE NEWSWIRE) -- CombiMatrix Corporation (NASDAQ:CBMX), a molecular diagnostics company specializing in DNA-based testing services for prenatal, miscarriage...